Correlation Between WUXI BIOLOGICS and CureVac NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both WUXI BIOLOGICS and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining WUXI BIOLOGICS and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between WUXI BIOLOGICS UNSPADR2 and CureVac NV, you can compare the effects of market volatilities on WUXI BIOLOGICS and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in WUXI BIOLOGICS with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of WUXI BIOLOGICS and CureVac NV.

Diversification Opportunities for WUXI BIOLOGICS and CureVac NV

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between WUXI and CureVac is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding WUXI BIOLOGICS UNSPADR2 and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and WUXI BIOLOGICS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on WUXI BIOLOGICS UNSPADR2 are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of WUXI BIOLOGICS i.e., WUXI BIOLOGICS and CureVac NV go up and down completely randomly.

Pair Corralation between WUXI BIOLOGICS and CureVac NV

Assuming the 90 days trading horizon WUXI BIOLOGICS UNSPADR2 is expected to under-perform the CureVac NV. In addition to that, WUXI BIOLOGICS is 1.18 times more volatile than CureVac NV. It trades about -0.05 of its total potential returns per unit of risk. CureVac NV is currently generating about -0.04 per unit of volatility. If you would invest  490.00  in CureVac NV on August 25, 2024 and sell it today you would lose (241.00) from holding CureVac NV or give up 49.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

WUXI BIOLOGICS UNSPADR2  vs.  CureVac NV

 Performance 
       Timeline  
WUXI BIOLOGICS UNSPADR2 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in WUXI BIOLOGICS UNSPADR2 are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, WUXI BIOLOGICS reported solid returns over the last few months and may actually be approaching a breakup point.
CureVac NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

WUXI BIOLOGICS and CureVac NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with WUXI BIOLOGICS and CureVac NV

The main advantage of trading using opposite WUXI BIOLOGICS and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if WUXI BIOLOGICS position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.
The idea behind WUXI BIOLOGICS UNSPADR2 and CureVac NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Transaction History
View history of all your transactions and understand their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities